Computational approaches to therapeutic antibody design: established methods and emerging trends

RA Norman, F Ambrosetti, AMJJ Bonvin… - Briefings in …, 2020 - academic.oup.com
Antibodies are proteins that recognize the molecular surfaces of potentially noxious
molecules to mount an adaptive immune response or, in the case of autoimmune diseases …

Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy

S Gupta, W Jiskoot, C Schöneich, AS Rathore - Journal of pharmaceutical …, 2022 - Elsevier
The role in human health of therapeutic proteins in general, and monoclonal antibodies
(mAbs) in particular, has been significant and is continuously evolving. A considerable …

[HTML][HTML] Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines

Y Guo, H Bera, C Shi, L Zhang, D Cun… - Acta Pharmaceutica Sinica …, 2021 - Elsevier
Pulmonary administration route has been extensively exploited for the treatment of local
lung diseases such as asthma, chronic obstructive pulmonary diseases and respiratory …

Surface-induced protein aggregation and particle formation in biologics: current understanding of mechanisms, detection and mitigation strategies

MRG Kopp, F Grigolato, D Zürcher, TK Das… - Journal of …, 2023 - Elsevier
Protein stability against aggregation is a major quality concern for the production of safe and
effective biopharmaceuticals. Amongst the different drivers of protein aggregation …

Evaluating and mitigating the immunogenicity of therapeutic proteins

ZE Sauna, D Lagassé, J Pedras-Vasconcelos… - Trends in …, 2018 - cell.com
Therapeutic proteins provide interventions for some of the most complex and intractable
diseases and are an essential part of modern medicine. Immunogenicity is the development …

Postproduction handling and administration of protein pharmaceuticals and potential instability issues

MR Nejadnik, TW Randolph, DB Volkin… - Journal of …, 2018 - Elsevier
The safety and efficacy of protein pharmaceuticals depend not only on biological activity but
also on purity levels. Impurities may be process related because of limitations in …

Particle detection and characterization for biopharmaceutical applications: current principles of established and alternative techniques

J Gross-Rother, M Blech, E Preis, U Bakowsky… - Pharmaceutics, 2020 - mdpi.com
Detection and characterization of particles in the visible and subvisible size range is critical
in many fields of industrial research. Commercial particle analysis systems have proliferated …

Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays

A Ducret, C Ackaert, J Bessa, C Bunce, T Hickling… - MAbs, 2022 - Taylor & Francis
ABSTRACT A major impediment to successful use of therapeutic protein drugs is their ability
to induce anti-drug antibodies (ADA) that can alter treatment efficacy and safety in a …

Challenges and strategies to enhance the systemic absorption of inhaled peptides and proteins

L Qin, Z Cui, Y Wu, H Wang, X Zhang, J Guan… - Pharmaceutical …, 2023 - Springer
Proteins and peptides-based therapeutics are making substantial access to the market due
to their obvious advantages of strong potency, high specificity and desirable safety profile …

In vivo characterizations of the immune properties of sericin: An ancient material with emerging value in biomedical applications

Z Jiao, Y Song, Y Jin, C Zhang, D Peng… - Macromolecular …, 2017 - Wiley Online Library
The biosafety of sericin remains controversial. The misunderstanding regarding sericin
causing adverse biological responses have been clarified by extensively reviewing relevant …